Concepts (258)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Endocarditis, Bacterial | 9 | 2019 | 344 | 1.77 | Why? |
| Saccharomycetales | 1 | 2019 | 118 | 0.74 | Why? |
| Fungemia | 1 | 2019 | 86 | 0.73 | Why? |
| Endocarditis | 6 | 2019 | 368 | 0.67 | Why? |
| Neurocysticercosis | 1 | 2017 | 51 | 0.63 | Why? |
| Congenital Abnormalities | 1 | 2018 | 170 | 0.62 | Why? |
| Microcephaly | 1 | 2018 | 181 | 0.62 | Why? |
| Zika Virus Infection | 2 | 2019 | 1920 | 0.57 | Why? |
| Guadeloupe | 5 | 2018 | 21 | 0.50 | Why? |
| Martinique | 4 | 2018 | 29 | 0.32 | Why? |
| France | 17 | 2021 | 12074 | 0.32 | Why? |
| Oral Hygiene | 2 | 2018 | 137 | 0.31 | Why? |
| Pregnancy Outcome | 1 | 2018 | 3803 | 0.28 | Why? |
| Antibiotic Prophylaxis | 2 | 2017 | 399 | 0.27 | Why? |
| Chikungunya Fever | 2 | 2018 | 345 | 0.26 | Why? |
| Gram-Positive Cocci | 1 | 2002 | 20 | 0.24 | Why? |
| Pregnancy Complications, Infectious | 2 | 2019 | 11559 | 0.24 | Why? |
| Anti-Bacterial Agents | 4 | 2019 | 10083 | 0.24 | Why? |
| Streptococcus | 2 | 2017 | 76 | 0.23 | Why? |
| French Guiana | 2 | 2018 | 83 | 0.23 | Why? |
| Cardiac Surgical Procedures | 3 | 2019 | 1931 | 0.21 | Why? |
| Leptospirosis | 1 | 2001 | 103 | 0.21 | Why? |
| Cardiobacterium | 1 | 2019 | 2 | 0.20 | Why? |
| Serologic Tests | 4 | 2021 | 4359 | 0.19 | Why? |
| Macaca fascicularis | 2 | 2021 | 1009 | 0.19 | Why? |
| Chromosome Disorders | 1 | 2018 | 24 | 0.18 | Why? |
| Echinocandins | 1 | 2019 | 139 | 0.18 | Why? |
| Antibodies, Viral | 7 | 2021 | 51949 | 0.18 | Why? |
| Pregnancy Trimesters | 1 | 2018 | 90 | 0.18 | Why? |
| Candida albicans | 1 | 2019 | 217 | 0.17 | Why? |
| Anticestodal Agents | 1 | 2016 | 10 | 0.17 | Why? |
| Voriconazole | 1 | 2019 | 206 | 0.17 | Why? |
| Drug Resistance, Fungal | 1 | 2019 | 191 | 0.17 | Why? |
| Kinetics | 3 | 2021 | 3238 | 0.17 | Why? |
| Echinococcosis, Hepatic | 1 | 2016 | 18 | 0.17 | Why? |
| Albendazole | 1 | 2016 | 32 | 0.17 | Why? |
| Cocaine-Related Disorders | 1 | 2017 | 51 | 0.16 | Why? |
| Amniotic Fluid | 1 | 2018 | 249 | 0.16 | Why? |
| Staphylococcus aureus | 4 | 2009 | 844 | 0.16 | Why? |
| Unsafe Sex | 1 | 2017 | 139 | 0.15 | Why? |
| Hepatitis C | 2 | 2018 | 1514 | 0.15 | Why? |
| Zika Virus | 2 | 2019 | 1924 | 0.15 | Why? |
| Fetal Diseases | 1 | 2018 | 182 | 0.15 | Why? |
| Practice Patterns, Dentists' | 1 | 2017 | 125 | 0.15 | Why? |
| Sustained Virologic Response | 1 | 2017 | 378 | 0.15 | Why? |
| Condoms | 1 | 2017 | 235 | 0.15 | Why? |
| Guillain-Barre Syndrome | 2 | 2019 | 1495 | 0.14 | Why? |
| Pre-Exposure Prophylaxis | 2 | 2021 | 1138 | 0.14 | Why? |
| Chikungunya virus | 1 | 2018 | 339 | 0.14 | Why? |
| HIV Infections | 5 | 2018 | 11620 | 0.14 | Why? |
| Antifungal Agents | 2 | 2019 | 1828 | 0.13 | Why? |
| Staphylococcal Infections | 3 | 2009 | 1099 | 0.13 | Why? |
| Streptococcal Infections | 1 | 2017 | 255 | 0.13 | Why? |
| Gram-Negative Bacterial Infections | 1 | 2019 | 398 | 0.13 | Why? |
| Spinal Diseases | 1 | 2016 | 238 | 0.13 | Why? |
| Iron | 1 | 1999 | 619 | 0.13 | Why? |
| Cohort Studies | 5 | 2021 | 36005 | 0.13 | Why? |
| Risk-Taking | 1 | 2017 | 508 | 0.12 | Why? |
| Diagnostic Errors | 1 | 2019 | 865 | 0.12 | Why? |
| Substance Abuse, Intravenous | 1 | 2017 | 411 | 0.12 | Why? |
| Mouth | 1 | 2017 | 622 | 0.12 | Why? |
| Microbial Sensitivity Tests | 1 | 2019 | 2886 | 0.10 | Why? |
| Decision Support Techniques | 1 | 2017 | 903 | 0.10 | Why? |
| Taste Disorders | 1 | 2021 | 1720 | 0.10 | Why? |
| Humans | 43 | 2021 | 930598 | 0.10 | Why? |
| Homosexuality, Male | 1 | 2018 | 1158 | 0.09 | Why? |
| Adult | 21 | 2021 | 244371 | 0.09 | Why? |
| Young Adult | 11 | 2021 | 93724 | 0.09 | Why? |
| Seizures | 1 | 2017 | 1163 | 0.09 | Why? |
| Clinical Audit | 1 | 2008 | 204 | 0.09 | Why? |
| Hepatitis C, Chronic | 1 | 2017 | 973 | 0.09 | Why? |
| Female | 23 | 2021 | 380317 | 0.09 | Why? |
| Hepacivirus | 1 | 2017 | 1509 | 0.09 | Why? |
| Plasma | 1 | 2017 | 1809 | 0.08 | Why? |
| Middle Aged | 23 | 2021 | 270681 | 0.08 | Why? |
| Diagnosis, Differential | 3 | 2019 | 7220 | 0.08 | Why? |
| Acute Disease | 1 | 2019 | 6029 | 0.08 | Why? |
| Immunity, Humoral | 1 | 2021 | 4849 | 0.08 | Why? |
| Hemorrhagic Fever, Ebola | 1 | 2017 | 1475 | 0.08 | Why? |
| Pregnancy | 2 | 2019 | 23879 | 0.08 | Why? |
| Patient Compliance | 1 | 2016 | 1468 | 0.08 | Why? |
| Pregnant Women | 1 | 2019 | 2535 | 0.08 | Why? |
| Bacterial Infections | 1 | 1999 | 2229 | 0.07 | Why? |
| Viral Load | 4 | 2021 | 15850 | 0.07 | Why? |
| Schools | 1 | 2021 | 4187 | 0.07 | Why? |
| Anti-HIV Agents | 1 | 2017 | 2209 | 0.07 | Why? |
| Adolescent | 10 | 2021 | 86841 | 0.07 | Why? |
| Prosthesis-Related Infections | 1 | 2008 | 302 | 0.07 | Why? |
| Guideline Adherence | 1 | 2017 | 2309 | 0.07 | Why? |
| Health Knowledge, Attitudes, Practice | 2 | 2017 | 8811 | 0.07 | Why? |
| Male | 25 | 2021 | 367725 | 0.07 | Why? |
| Europe | 3 | 2017 | 12702 | 0.07 | Why? |
| Travel | 3 | 2017 | 7220 | 0.07 | Why? |
| Heart Diseases | 2 | 2017 | 3503 | 0.07 | Why? |
| Virginiamycin | 1 | 2002 | 5 | 0.06 | Why? |
| Olfaction Disorders | 1 | 2021 | 3704 | 0.06 | Why? |
| Oxazolidinones | 1 | 2002 | 49 | 0.06 | Why? |
| Heart Valve Prosthesis | 1 | 2008 | 533 | 0.06 | Why? |
| HIV-1 | 1 | 2017 | 3365 | 0.06 | Why? |
| Aircraft | 2 | 2004 | 498 | 0.06 | Why? |
| Renal Dialysis | 1 | 1999 | 4358 | 0.06 | Why? |
| Enterococcus | 1 | 2002 | 73 | 0.06 | Why? |
| Aminoglycosides | 1 | 2002 | 94 | 0.06 | Why? |
| Immunoglobulin M | 1 | 2019 | 9091 | 0.06 | Why? |
| Immunoglobulin G | 3 | 2021 | 21571 | 0.06 | Why? |
| Disease Outbreaks | 3 | 2018 | 27595 | 0.06 | Why? |
| Linezolid | 1 | 2002 | 160 | 0.05 | Why? |
| Seroepidemiologic Studies | 3 | 2021 | 10017 | 0.05 | Why? |
| Magnetic Resonance Imaging | 2 | 2017 | 6551 | 0.05 | Why? |
| Acetamides | 1 | 2002 | 141 | 0.05 | Why? |
| Odds Ratio | 3 | 2017 | 5861 | 0.05 | Why? |
| Tropical Climate | 1 | 2001 | 179 | 0.05 | Why? |
| Infant, Newborn | 2 | 2021 | 23105 | 0.05 | Why? |
| Penicillins | 1 | 2001 | 132 | 0.05 | Why? |
| Jaundice | 1 | 2001 | 114 | 0.05 | Why? |
| Child | 5 | 2021 | 70012 | 0.05 | Why? |
| Aged, 80 and over | 6 | 2021 | 88759 | 0.05 | Why? |
| Hematuria | 1 | 2001 | 284 | 0.05 | Why? |
| Hydroxychloroquine | 2 | 2021 | 12447 | 0.05 | Why? |
| Immunoprecipitation | 1 | 2020 | 300 | 0.05 | Why? |
| Drug Resistance | 1 | 2002 | 395 | 0.05 | Why? |
| Water Microbiology | 1 | 2001 | 248 | 0.05 | Why? |
| Antigen-Antibody Reactions | 1 | 2021 | 616 | 0.05 | Why? |
| Hemoptysis | 1 | 2001 | 172 | 0.05 | Why? |
| Hospital Mortality | 4 | 2019 | 22087 | 0.05 | Why? |
| Antibody-Dependent Cell Cytotoxicity | 1 | 2021 | 349 | 0.05 | Why? |
| Risk Factors | 8 | 2021 | 71621 | 0.05 | Why? |
| Luciferases | 1 | 2020 | 378 | 0.05 | Why? |
| Purpura | 1 | 2001 | 310 | 0.04 | Why? |
| Crack Cocaine | 1 | 2017 | 8 | 0.04 | Why? |
| Iron Overload | 1 | 1999 | 113 | 0.04 | Why? |
| Echinococcus multilocularis | 1 | 2016 | 5 | 0.04 | Why? |
| Bacteria | 2 | 2017 | 1897 | 0.04 | Why? |
| Complement System Proteins | 1 | 2021 | 380 | 0.04 | Why? |
| Epidemics | 1 | 2017 | 6407 | 0.04 | Why? |
| Echinococcosis | 1 | 2016 | 40 | 0.04 | Why? |
| Neutralization Tests | 2 | 2021 | 6698 | 0.04 | Why? |
| Behcet Syndrome | 1 | 1998 | 136 | 0.04 | Why? |
| Hepatitis C Antibodies | 1 | 2017 | 120 | 0.04 | Why? |
| Antibody Specificity | 1 | 2021 | 1328 | 0.04 | Why? |
| Streptococcus pneumoniae | 1 | 2002 | 827 | 0.04 | Why? |
| In Vitro Techniques | 1 | 2020 | 1027 | 0.04 | Why? |
| Vomiting | 1 | 2001 | 722 | 0.04 | Why? |
| Spike Glycoprotein, Coronavirus | 3 | 2021 | 37182 | 0.04 | Why? |
| Practice Guidelines as Topic | 2 | 2017 | 15421 | 0.04 | Why? |
| Trachea | 1 | 2021 | 894 | 0.04 | Why? |
| Aged | 12 | 2021 | 215776 | 0.04 | Why? |
| Antibodies, Neutralizing | 2 | 2020 | 25288 | 0.04 | Why? |
| Middle East Respiratory Syndrome Coronavirus | 1 | 2017 | 8843 | 0.04 | Why? |
| Retrospective Studies | 4 | 2021 | 105322 | 0.04 | Why? |
| Habits | 1 | 2018 | 334 | 0.04 | Why? |
| Healthy Volunteers | 1 | 2020 | 1444 | 0.03 | Why? |
| Encephalitis, Tick-Borne | 1 | 1995 | 86 | 0.03 | Why? |
| Chi-Square Distribution | 1 | 2017 | 961 | 0.03 | Why? |
| Treatment Failure | 1 | 2020 | 2106 | 0.03 | Why? |
| Pain | 1 | 2001 | 1084 | 0.03 | Why? |
| Clinical Laboratory Techniques | 1 | 2020 | 23402 | 0.03 | Why? |
| Time Factors | 4 | 2020 | 31397 | 0.03 | Why? |
| Hydrocortisone | 1 | 2003 | 1790 | 0.03 | Why? |
| Incidence | 3 | 2018 | 25622 | 0.03 | Why? |
| Disease Models, Animal | 2 | 2021 | 10998 | 0.03 | Why? |
| Disease Reservoirs | 1 | 2001 | 1672 | 0.03 | Why? |
| Antiretroviral Therapy, Highly Active | 1 | 2017 | 952 | 0.03 | Why? |
| Coronavirus Infections | 5 | 2020 | 253789 | 0.03 | Why? |
| Equipment and Supplies | 1 | 2017 | 440 | 0.03 | Why? |
| Flow Cytometry | 1 | 2020 | 2393 | 0.03 | Why? |
| Respiratory Mucosa | 1 | 2020 | 1522 | 0.03 | Why? |
| Hygiene | 1 | 2018 | 987 | 0.03 | Why? |
| Killer Cells, Natural | 1 | 2021 | 2093 | 0.03 | Why? |
| Dentistry | 1 | 2017 | 621 | 0.03 | Why? |
| Animals | 4 | 2021 | 78931 | 0.03 | Why? |
| Prospective Studies | 5 | 2017 | 43301 | 0.03 | Why? |
| Polymerase Chain Reaction | 2 | 2003 | 6740 | 0.03 | Why? |
| Area Under Curve | 1 | 2017 | 2564 | 0.02 | Why? |
| Severe Acute Respiratory Syndrome | 2 | 2004 | 12361 | 0.02 | Why? |
| Postoperative Complications | 1 | 2008 | 5861 | 0.02 | Why? |
| Cross Reactions | 1 | 2021 | 4374 | 0.02 | Why? |
| United States | 1 | 2017 | 46150 | 0.02 | Why? |
| Hospitals | 2 | 2020 | 11793 | 0.02 | Why? |
| Coagulase | 1 | 2008 | 44 | 0.02 | Why? |
| Basic Reproduction Number | 1 | 2021 | 2676 | 0.02 | Why? |
| Follow-Up Studies | 2 | 2018 | 17020 | 0.02 | Why? |
| Antiviral Agents | 3 | 2021 | 41703 | 0.02 | Why? |
| Case-Control Studies | 2 | 2018 | 17671 | 0.02 | Why? |
| Epitopes | 1 | 2021 | 4113 | 0.02 | Why? |
| Seasons | 1 | 2021 | 4071 | 0.02 | Why? |
| Asymptomatic Diseases | 1 | 2021 | 3444 | 0.02 | Why? |
| Cytokines | 2 | 2021 | 15010 | 0.02 | Why? |
| Antibody Formation | 1 | 2021 | 4038 | 0.02 | Why? |
| Betacoronavirus | 3 | 2020 | 204454 | 0.02 | Why? |
| Cough | 1 | 2001 | 4891 | 0.02 | Why? |
| Pneumonia, Viral | 3 | 2020 | 243684 | 0.02 | Why? |
| Sexual Behavior | 1 | 2017 | 1322 | 0.02 | Why? |
| Recurrence | 1 | 2017 | 3675 | 0.02 | Why? |
| Zoonoses | 1 | 2001 | 3034 | 0.02 | Why? |
| Treatment Outcome | 4 | 2017 | 51732 | 0.02 | Why? |
| Amphotericin B | 1 | 2008 | 256 | 0.02 | Why? |
| Bioprosthesis | 1 | 2008 | 126 | 0.02 | Why? |
| Cross Infection | 2 | 2008 | 8675 | 0.02 | Why? |
| Prognosis | 2 | 2019 | 32490 | 0.02 | Why? |
| Infant | 2 | 2021 | 30274 | 0.02 | Why? |
| Bacteremia | 1 | 2017 | 1372 | 0.02 | Why? |
| Disease Susceptibility | 1 | 1999 | 4002 | 0.02 | Why? |
| Multivariate Analysis | 1 | 2017 | 5440 | 0.02 | Why? |
| Methicillin Resistance | 1 | 2005 | 77 | 0.02 | Why? |
| Child, Preschool | 2 | 2021 | 36283 | 0.02 | Why? |
| Prescription Drugs | 1 | 2008 | 243 | 0.02 | Why? |
| Statistics, Nonparametric | 1 | 2008 | 1008 | 0.02 | Why? |
| Risk | 1 | 2017 | 5288 | 0.02 | Why? |
| Azithromycin | 1 | 2020 | 3943 | 0.02 | Why? |
| Genotype | 1 | 2017 | 4697 | 0.02 | Why? |
| Liver Cirrhosis | 1 | 2016 | 1810 | 0.02 | Why? |
| ROC Curve | 1 | 2017 | 6024 | 0.02 | Why? |
| Epidemiological Monitoring | 1 | 2018 | 3493 | 0.02 | Why? |
| Enzyme-Linked Immunosorbent Assay | 1 | 2020 | 7868 | 0.02 | Why? |
| Lung Diseases | 1 | 1998 | 2361 | 0.02 | Why? |
| Fever | 1 | 2001 | 7795 | 0.02 | Why? |
| Drug Resistance, Microbial | 1 | 2008 | 419 | 0.02 | Why? |
| Disease Management | 1 | 2002 | 6841 | 0.02 | Why? |
| Risk Assessment | 2 | 2019 | 25439 | 0.02 | Why? |
| Vero Cells | 1 | 2020 | 14117 | 0.02 | Why? |
| Proportional Hazards Models | 1 | 2016 | 6543 | 0.02 | Why? |
| Severity of Illness Index | 2 | 2021 | 48226 | 0.01 | Why? |
| Logistic Models | 1 | 2017 | 9089 | 0.01 | Why? |
| Predictive Value of Tests | 1 | 2017 | 9537 | 0.01 | Why? |
| Global Health | 2 | 2005 | 13911 | 0.01 | Why? |
| Clinical Trials as Topic | 1 | 2021 | 7330 | 0.01 | Why? |
| Cross-Sectional Studies | 2 | 2021 | 53120 | 0.01 | Why? |
| Nasopharynx | 1 | 2021 | 10224 | 0.01 | Why? |
| RNA, Viral | 2 | 2020 | 32276 | 0.01 | Why? |
| Societies, Medical | 1 | 2017 | 6907 | 0.01 | Why? |
| Sensitivity and Specificity | 1 | 2021 | 22971 | 0.01 | Why? |
| Health Personnel | 2 | 2021 | 29646 | 0.01 | Why? |
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2020 | 13720 | 0.01 | Why? |
| Alkylating Agents | 1 | 1998 | 12 | 0.01 | Why? |
| Surveys and Questionnaires | 2 | 2017 | 43792 | 0.01 | Why? |
| Virus Replication | 1 | 2021 | 14331 | 0.01 | Why? |
| Vietnam | 1 | 2004 | 1665 | 0.01 | Why? |
| Coinfection | 1 | 2017 | 6820 | 0.01 | Why? |
| Cyclophosphamide | 1 | 1998 | 387 | 0.01 | Why? |
| Ribavirin | 1 | 2003 | 1182 | 0.01 | Why? |
| Pandemics | 5 | 2021 | 389249 | 0.01 | Why? |
| Hospitals, University | 1 | 2008 | 4173 | 0.01 | Why? |
| Prevalence | 1 | 2017 | 25773 | 0.01 | Why? |
| Prednisone | 1 | 1998 | 652 | 0.01 | Why? |
| Patient Readmission | 1 | 2003 | 1543 | 0.01 | Why? |
| Stroke | 1 | 2017 | 8839 | 0.01 | Why? |
| Patient Isolation | 1 | 2003 | 3182 | 0.01 | Why? |
| Drug Therapy, Combination | 1 | 2003 | 7268 | 0.01 | Why? |
| Echocardiography | 1 | 1998 | 3661 | 0.00 | Why? |
| Anti-Inflammatory Agents | 1 | 2003 | 6153 | 0.00 | Why? |
| Glucocorticoids | 1 | 1998 | 4431 | 0.00 | Why? |
| Delivery of Health Care | 1 | 2008 | 15909 | 0.00 | Why? |
| Anticoagulants | 1 | 1998 | 9563 | 0.00 | Why? |
| Tomography, X-Ray Computed | 1 | 2003 | 25144 | 0.00 | Why? |
| China | 1 | 2003 | 50654 | 0.00 | Why? |
| Lung | 1 | 2003 | 31049 | 0.00 | Why? |
| Coronavirus | 1 | 2003 | 18339 | 0.00 | Why? |